Study Observes Predictor of Response to Ursodeoxycholic Acid Treatment for PBC
A study presented at the AASLD Liver Meeting found that microbiome subtypes may predict patients' response to ursodeoxycholic acid (UDCA) treatment for primary biliary...
Study Compares Hepatic Event Outcomes in Patients With PBC Based on Ethnicity
A study presented at the AASLD Liver Meeting found that Latino and Hispanic patients with primary biliary cholangitis (PBC) were more likely to experience...
Real-world Study Highlights Indicators of More Severe Liver Fibrosis Among Patients With PBC
A study assessed demographic, socioeconomic, and disease-related factors to determine any impacts to primary biliary cholangitis (PBC) outcomes. The study, presented at the AASLD...
3-year Study Outcomes Demonstrate ‘Durable’ Response to Seladelpar for PBC
A late-breaking abstract presented at the AASLD Liver Meeting showed a “durable and sustained biochemical response” to seladelpar in patients with primary biliary cholangitis...